Live Breaking News & Updates on A Paradigm Shift For Depression Research

Stay updated with breaking news from A paradigm shift for depression research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Freedom Biosciences Announces FDA Approval of IND Application for FREE001 in Patients with Treatment-Resistant Depression

/PRNewswire/ Freedom Biosciences, Inc. ("Freedom Bio" or the "Company"), a clinical-stage biotechnology platform focused on developing next-generation. ....

United States , Jannsen Spravato , Dina Burkitbayeva , David Hough , Smith Carls , John Krystal , Rob Berman , Ius Dept Of Health , Biohaven Pharmaceuticals , National Survey On Drug , Mental Health Services Administration , Freedom Biosciences Inc , Mental Health Indicators , Drug Administration , Human Services , National Burden Of Treatment , Psychiatry At Yale University , A Paradigm Shift For Depression Research , Freedom Bio , Chief Scientific Advisor , Yale University , Psymed Ventures , Chief Medical Officer , Senior Medical Advisor , Scientific Advisory Board , Paradigm Shift ,